FTRE Logo

Fortrea Holdings Inc. (FTRE) 

NASDAQ
Market Cap
$1.68B
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
673 of 960
Rank in Industry
373 of 550

Largest Insider Buys in Sector

FTRE Stock Price History Chart

FTRE Stock Performance

About Fortrea Holdings Inc.

Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. It operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The …

Insider Activity of Fortrea Holdings Inc.

Over the last 12 months, insiders at Fortrea Holdings Inc. have bought $0 and sold $0 worth of Fortrea Holdings Inc. stock.

On average, over the past 5 years, insiders at Fortrea Holdings Inc. have bought $504,640 and sold $0 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 20,000 shares for transaction amount of $504,640 was made by Pike Thomas (Chief Executive Officer) on 2023‑08‑23.

List of Insider Buy and Sell Transactions, Fortrea Holdings Inc.

2023-08-23PurchaseChief Executive Officer
20,000
0.0267%
$25.23$504,640+16.84%

Insider Historical Profitability

16.84%
Pike ThomasChief Executive Officer
20000
0.0223%
$18.7810+16.84%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.